메뉴 건너뛰기




Volumn 14, Issue 4, 1996, Pages 375-388

A strategy for validation of bioanalytical methods

Author keywords

Bioanalytical methods; Drug development; Validation

Indexed keywords

ACCURACY; ANALYTIC METHOD; AUTOMATION; DRUG DEVELOPMENT; DRUG STABILITY; PRIORITY JOURNAL; QUALITY CONTROL; RADIOIMMUNOASSAY; SHORT SURVEY; STANDARD; TECHNIQUE;

EID: 0029893819     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/0731-7085(95)01644-9     Document Type: Article
Times cited : (167)

References (20)
  • 9
    • 85030202101 scopus 로고    scopus 로고
    • The Rules governing Medicinal Products in the European Community, Addendum 3, European Communities Commission Luxembourg
    • C.P.M.P Notes of Guidance: Analytical validation, The Rules governing Medicinal Products in the European Community, Addendum 3, European Communities Commission Luxembourg.
    • C.P.M.P Notes of Guidance: Analytical Validation
  • 11
    • 0009571137 scopus 로고
    • E. Reids, H.M. Hill and I.D. Wilson (Eds.), The Royal Society of Chemistry
    • R.W. Abbot, G.D. Allen and G. Rhodes, in E. Reids, H.M. Hill and I.D. Wilson (Eds.), Biofluids and Tissue Analysis for Drugs, Vol 23 The Royal Society of Chemistry, 1994, pp 255-256.
    • (1994) Biofluids and Tissue Analysis for Drugs , vol.23 , pp. 255-256
    • Abbot, R.W.1    Allen, G.D.2    Rhodes, G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.